Detalhe da pesquisa
1.
Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset.
Mult Scler
; 25(7): 918-926, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882478
2.
Acute simultaneous development of brain tumour-like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis.
Mult Scler
; 24(4): 546-550, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795610
3.
Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis.
Ophthalmology
; 127(12): 1774-1776, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359844
4.
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.
J Neurol Neurosurg Psychiatry
; 90(11): 1293-1296, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952681
5.
Tübingen model study: large-scale introduction of rapid antigen testing in the population and the viral dynamics of SARS-CoV-2.
Front Public Health
; 11: 1159622, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942246
6.
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Mult Scler
; 18(2): 174-80, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868488
7.
Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis.
Front Immunol
; 11: 174, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32194540
8.
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review.
Mult Scler Relat Disord
; 30: 262-264, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851640
9.
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon.
Ther Adv Neurol Disord
; 11: 1756285617741056, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399047
10.
NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis.
Ther Adv Neurol Disord
; 11: 1756286418805713, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30386435
11.
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
PLoS One
; 12(8): e0183957, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28850630
12.
Cerebrospinal fluid IL-1ß correlates with cortical pathology load in multiple sclerosis at clinical onset.
J Neuroimmunol
; 270(1-2): 56-60, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24657029
13.
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy.
Neurol Neuroimmunol Neuroinflamm
; 5(1): e420, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29259997